Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Chinese biotech firms eye foreign pharma's fat profits in weight loss drug market
When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due to hormonal imbalances that slowed her metabolism. She reached a peak weight of 100kg about a year ago, but has since lost 25kg. The secret to…
After City of Hope's new AI dropped, execs got hugs and pharma came calling
news article Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. ✓ Link copied to clipboard! There is no shortage of health care AI applications on the market…
Pharma exporters seek time to comply with online only submission for COPP
Pharma exporters body Pharmexcil has appealed to the Central Drugs Standard Control Organisation (CDSCO) and Union Ministry of Health and Family Welfare to defer a proposal to only permit applications on ONDLS portal for certificate of…
Wockhardt to exit US generic pharma segment, shut down 2 subsidiaries
Amid the ongoing trade tariff related concerns, Indian pharmaceutical firm Wockhardt Ltd on Friday said it has decided to exit the US generic pharmaceutical segment, paving the way for deeper focus and investment in its advanced product portfolio.
Marksans Pharma fixes record date for final dividend
Last Updated: Jul 11 2025 | 3:04 PM IST Marksans Pharma has fixed 01 August 2025 as record date for determining eligibility of Members to receive final dividend for the financial year ended 31 March 2025. The final dividend, if approved at the AGM…
Glenmark Pharma shares surge 10%, hit upper circuit limit
At the NSE, the stock zoomed 10 per cent to Rs 2,094.40 — its 52-week high as well as upper circuit level. Glenmark Pharmaceuticals' arm Ichnos Glenmark Innovation has signed the deal for its lead investigational asset ‘ISB 2001'. ISB…
Aurobindo Pharma Ltd drops for fifth straight session
Aurobindo Pharma Ltd is quoting at Rs 1126.3, down 0.32% on the day as on 13:19 IST on the NSE. The stock tumbled 15.11% in last one year as compared to a 2.68% rally in NIFTY and a 7.89% spurt in the Nifty Pharma index. Aurobindo Pharma Ltd fell…
Wockhardt exits US generic pharma business, files for liquidation of subsidiaries
Mumbai-headquartered pharmaceutical firm Wockhardt Ltd on Friday said that it has taken the decision to exit the United States (US) generic pharmaceutical segment as part of a broader realignment of its global strategy. The company stated that the…
Gland Pharma's Pashamylaram facility receives GMP certification from Danish Medicines Agency
Last Updated: Jul 11 2025 | 5:31 PM IST For aseptically prepared Powder for injection, infusion and inhalation Gland Pharma announced that the Pashamylaram facility of the Company has received certificate of Good Manufacturing Practices (GMP)…
The Top Nine Technology Trends Reshaping Life Sciences Supply Chains
Mike Walker is Vice President, Global Life Sciences Strategy, at Microsoft. Bringing paradigm-shifting digital innovations. From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain…
Glenmark Pharma soars on AbbVie licensing deal for cancer therapy ISB 2001
Glenmark Pharmaceuticals hit an upper limit of 10% to a record high of Rs 2095.65 after its subsidiary Ichnos Glenmark Innovation (IGI) unveiled a global commercialization strategy for its lead investigational oncology asset, ISB 2001. The…
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma
Merck has reached a $10 billion deal to acquire Verona Pharma, a biotech whose first-in-class drug is already commercialized in one prevalent lung disorder and is showing promise in other respiratory conditions. The multi-blockbuster potential of…
Glenmark Pharma shares surge after its U.S arm, AbbVie ink pact for investigational cancer drug
The share prices of Glenmark Pharmaceuticals surged 10% to ₹2,095.65 each, hitting the upper circuit in the process, as soon as markets opened on Friday (June 11, 2025) in the backdrop of an exclusive licensing agreement for investigational…
Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts (NASDAQ:TERN)
Terns Pharmaceuticals, Inc. offers two differentiated late-stage assets—TERN-701 for CML and TERN-601 for obesity—with major data catalysts expected in Q4 2025. TERN-701 shows early signs of best-in-class potential in CML, with…
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - AbbVie (NYSE:ABBV), Amgen (NASDAQ:AMGN)
While President Donald Trump 's proposed 200% tariffs on pharmaceutical imports could potentially squeeze the profit margins, this stock is poised to “benefit” from the levies. What Happened: Trump announced on Tuesday that the pharma…
Receive a Daily briefing on Pharma Industry News
Get Started